Article
Genomic instabilities in hepatocellular carcinoma: biomarkers and application in immunotherapies
14 Aug 2024
Abstract excerpt
Hepatocellular carcinoma (HCC) is one of the deadliest cancers. For patients with advanced HCC, liver function decompensation often occurs, which leads to poor tolerance to chemotherapies and other aggressive treatments. Therefore, it remains critical to develop effective therapeutic strategies for HCC. Etiological factors for HCC are complex and multifaceted, including hepatitis virus infection, alcohol, drug...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
